FF — Fine Foods & Pharmaceuticals NTM SpA Cashflow Statement
0.000.00%
- €178.72m
- €214.03m
- €243.75m
- 71
- 46
- 39
- 50
Annual cashflow statement for Fine Foods & Pharmaceuticals NTM SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 13.4 | -1.43 | -9.5 | -3.52 | 8.16 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.572 | 11.9 | 14.6 | 8.25 | 5.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 5.57 | -27.8 | -12.2 | -4.1 | 13.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 30.5 | -5.83 | 3.69 | 18.5 | 45.9 |
Capital Expenditures | -15.8 | -15.9 | -16 | -18.9 | -34.7 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 3.47 | -20.4 | 0.67 | 64.8 | 3.17 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -12.3 | -36.3 | -15.3 | 45.9 | -31.6 |
Financing Cash Flow Items | 0 | — | — | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -17.4 | 56 | 4.74 | -55.7 | -14.1 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.715 | 13.8 | -6.89 | 8.77 | 0.21 |